ESPR — ESPERION THERAPEUTICS INC NE

Ownership history in AXQ CAPITAL, LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which AXQ CAPITAL, LP reported a position in ESPERION THERAPEUTICS INC NE (ESPR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.21% (2022 Q4)
Avg. % of fund
0.12%
First filed
2022 Q4
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 38,930 -9,131 -19.0% 0.04% $103K $2.65
2022 Q4 INITIATED 48,061 — — 0.21% $299K —
% of Fund (quarterly)    ESPR price (monthly, adj. close)

Other funds also holding ESPR

As of 2025 Q4 — sorted by position size

AIGH Capital Management LLC 3Y 3.58% Velan Capital Investment Management LP 3Y 2.6% PenderFund Capital Management Ltd. 3Y 7Y 2.56% Two Seas Capital LP 3Y 0.91% Eversept Partners, LP 3Y 7Y 0.72% nVerses Capital, LLC 0.56% ORBIMED ADVISORS LLC 3Y 7Y 0.45% Summit Wealth Group, LLC 3Y 0.29% WASATCH ADVISORS LP 3Y 7Y 0.21% Virtus Investment Advisers, LLC 3Y 7Y 0.18%
← Back to AXQ CAPITAL, LP Holdings